The expression of JMJD4 was also higher in bladder cancer, breast cancer, cholangiocarcinoma, colon cancer, renal cancer, lung cancer, etc., than in normal tissue (p < 0.01 or p < 0.001, Figure 1(c)). Here, JMJD4 is linked to cholangiocarcinoma.